These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7878893)
41. The University of California at Los Angeles heart transplantation experience. Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A Clin Transpl; 2005; ():173-85. PubMed ID: 17424734 [TBL] [Abstract][Full Text] [Related]
42. Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantation. Frey B; Zuckermann A; Koller-Strametz J; Rödler S; Hülsmann M; Stanek B; Grimm M; Laufer G; Pacher R Transplant Proc; 1999; 31(1-2):80-1. PubMed ID: 10083016 [No Abstract] [Full Text] [Related]
43. [Report from Stanford: Improved results in heart transplantation after reduced immunosuppression]. Samuelsson R Lakartidningen; 1980 Jun; 77(25):2340-4. PubMed ID: 6995748 [No Abstract] [Full Text] [Related]
44. Morbidity and mortality among heart transplant patients older and younger than 65 years. Crespo-Leiro MG; Paniagua MJ; Rodriguez JA; Hermida LF; Fojón S; Vazquez N; Muñiz J; Cuenca JJ; Juffe-Stein A; Castro-Beiras A Transplant Proc; 1999 Sep; 31(6):2537-8. PubMed ID: 10500706 [No Abstract] [Full Text] [Related]
49. [Evaluation, with a polygraphic method, of cardiac dynamics after insertion of a valve prosthesis]. Iarussi D; Vitale P; Ferrante MR; Vosa C; Jacono A Boll Soc Ital Cardiol; 1978; 23(4):796-803. PubMed ID: 757364 [No Abstract] [Full Text] [Related]
50. [Surgical management of cardiovascular disorders, therapy and results: heart transplantation]. Sebening F Verh Dtsch Ges Kreislaufforsch; 1970; 36():173-81. PubMed ID: 4927225 [No Abstract] [Full Text] [Related]
51. Evaluating the donor pool: impact of using hearts from donors over the age of 49 years. Mercer P; Sharples L; Edmunds J; Gittins R; Baines J; Wallwork J; Large S; Parameshwar J Transplant Proc; 1997 Dec; 29(8):3293-6. PubMed ID: 9414720 [No Abstract] [Full Text] [Related]
52. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Zuckermann A; Ploner M; Czerny M; Keziban U; Birsan T; Laufer G; Wolner E; Grimm M Transplant Proc; 2002 Aug; 34(5):1869-71. PubMed ID: 12176608 [No Abstract] [Full Text] [Related]
53. Infection in heart transplant recipients: seven years' experience at the National Taiwan University Hospital. Ko WJ; Chien NC; Chou NK; Wang SS; Chu SH; Chang SC Transplant Proc; 2000 Nov; 32(7):2392-5. PubMed ID: 11120213 [No Abstract] [Full Text] [Related]
57. [Surgical treatment of acquired valvular cardiopathies (preliminary contribution)]. Chidichimo G; Tomai F; Massa E Policlinico Chir; 1968; 75(2):88-113. PubMed ID: 5740020 [No Abstract] [Full Text] [Related]
58. [Prognostic significance of the central hemodynamic reaction to functional tests in patients operated on for acquired heart defects]. Morozov MV; Ivannikov MN; Klembovskiĭ A Anesteziol Reanimatol; 1988; (5):13-7. PubMed ID: 3218770 [No Abstract] [Full Text] [Related]
59. [A clinical study of valvular heart disease with RVEDP higher than 15 mmHg (author's transl)]. Nakano K; Hashimoto A; Kurosawa H; Ishihara S; Nishida H; Hayashi H; Koyanagi H Kyobu Geka; 1982; 35(4):253-9. PubMed ID: 7109375 [No Abstract] [Full Text] [Related]
60. Cardiac transplantation in patients over 60 years of age. Baron O; Trochu JN; Treilhaud M; al Habash O; Remadi JP; Petit T; Duveau D; Despins P; Michaud JL Transplant Proc; 1999; 31(1-2):75-8. PubMed ID: 10083014 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]